Cancer Letters
Volume 238, Issue 2 , Pages 230-239 , 18 July 2006

Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization

  • Si-Long Qin

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • Department of Pathology, Beijing Army General Hospital, Beijing 100700, China
    • Both the authors contributed equally to this work.
    • ,
  • Xian-Jun Chen

      Affiliations

    • Biology Department, Xianning Medical College, Xianning 437100, China
    • Both the authors contributed equally to this work.
    • ,
  • Xin Xu

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Jian-Zhong Shou

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Xin-Gang Bi

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Liang Ji

      Affiliations

    • Department of Automation, Tsinghua University, Beijing 100084, China
    • ,
  • Ya-Ling Han

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Yan Cai

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Fang Wei

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Jian-Hui Ma

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Min Wu

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Qi-Min Zhan

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • ,
  • Ming-Rong Wang

      Affiliations

    • State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, P.O. Box 2258, Beijing 100021, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 10 87788425; fax: +86 10 87778651.

Received 18 May 2005 ,Revised 8 July 2005 ,Accepted 10 July 2005.

References 

  1. Zhang ZF, Shu XM, Cordon-Cardo C, Orlow I, Lu ML, Millon TV, et al. Cigarette smoking and chromosome 9 alterations in bladder cancer. Cancer Epidemiol. Biomarkers. Prev. 1997;6:321–326
  2. Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knonagel H, et al. Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res. 1999;59:5687–5691
  3. Koo SH, Kwon KC, Ihm CH, Jeon YM, Park JW, Sul CK. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. Cancer Genet. Cytogenet. 1999;110:87–93
  4. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L, Terpe HJ. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J. Pathol. 1998;185:345–351
  5. Richter J, Beffa L, Wagner U, Schraml P, Gasser TC, Moch H, et al. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am. J. Pathol. 1998;153:1615–1621
  6. Sauter G. [Rudolf Virchow Prize 1997. Molecular cytogenetic analysis of superficial urothelial cancer of the bladder]. Verh. Dtsch. Ges. Pathol. 1997;81:18–27
  7. Richter J, Jiang F, Gorog JP, Sartorius G, Egenter C, Gasser TC, et al. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res. 1997;57:2860–2864
  8. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer. 1995;12:213–219
  9. Ohta JI, Miyoshi Y, Uemura H, Fujinami K, Mikata K, Hosaka M, et al. Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer. Clin. Cancer Res. 2001;7:2463–2467
  10. Baud E, Catilina P, Bignon YJ. p16 involvement in primary bladder tumors: analysis of deletions and mutations. Int. J. Oncol. 1999;14:441–445
  11. Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CH, Busch C, Shamaa M, et al High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J. Natl Cancer Inst. 1995;87:1383–1393
  12. Bruch J, Wohr G, Hautmann R, Mattfeldt T, Bruderlein S, Moller P, et al. Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q. Genes Chromosomes Cancer. 1998;23:167–174
  13. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003;63:2872–2880
  14. Prat E, Bernues M, Caballin MR, Egozcue J, Gelabert A, Miro R. Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization. Urology. 2001;57:986–992
  15. Simon R, Burger H, Semjonow A, Hertle L, Terpe HJ, Bocker W. Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int. J. Oncol. 2000;17:1025–1029
  16. Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder. Cancer Res. 2003;63:7652–7656
  17. Kimura F, Florl AR, Seifert HH, Louhelainen J, Maas S, Knowles MA, et al. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Br. J. Cancer. 2001;85:1887–1893
  18. Nilsson M, Meza-Zepeda LA, Mertens F, Forus A, Myklebost O, Mandahl N. Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int. J. Cancer. 2004;109:363–369
  19. Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, et al. Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene. 2002;21:2261–2269
  20. Katoh M. WNT and FGF gene clusters (review). Int. J. Oncol. 2002;21:1269–1273
  21. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am. J. Pathol. 2000;157:787–794
  22. Yeager TR, DeVries S, Jarrard DF, Kao C, Nakada SY, Moon TD, et al. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev. 1998;12:163–174
  23. Kimura F, Seifert HH, Florl AR, Santourlidis S, Steinhoff C, Swiatkowski S, et al. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int. J. Cancer. 2003;104:568–578
  24. Bohm M, Kirch H, Otto T, Rubben H, Wieland I. Deletion analysis at the DEL-27, APC and MTS1 loci in bladder cancer: LOH at the DEL-27 locus on 5p13-12 is a prognostic marker of tumor progression. Int. J. Cancer. 1997;74:291–295
  25. Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum. Mol. Genet. 1995;4:1569–1577
  26. Berggren P, Kumar R, Sakano S, Hemminki L, Wada T, Steineck G, et al. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin. Cancer Res. 2003;9:235–242
  27. Brewster SF, Gingell JC, Browne S, Brown KW. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br. J. Cancer. 1994;70:697–700
  28. Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int. J. Cancer. 1993;53:781–784
  29. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 1994;10:231–243

PII: S0304-3835(05)00669-5

doi: 10.1016/j.canlet.2005.07.010

Cancer Letters
Volume 238, Issue 2 , Pages 230-239 , 18 July 2006

Article Tools

* Image Usage & Resolution